DNA Virus Infections  >>  cisplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cisplatin / Generic mfg.
NCT02983097 / 2009-010824-25: Therapy of Non-Hodgkin-Lymphoma by Combination of Lenalidomide + Rituximab, Dexa, High-dose ARA-C and CisP

Terminated
1/2
34
Europe
Rituximab, MabThera, Cisplatin, Cisplatinum, Carboplatin, Carboplatinum, Dexamethasone, Cytarabine, Cytarabin, Ara-C, Lenalidomide, Revlimid, PegFilgrastim, Neulasta, peripheral stem cell collection, peripheral stem cell apheresis, hematopoetic stem cell apheresis, peripheral hematopoetic stem cell apheresis
Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH, Celgene, Amgen
Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma Grade III (FL III°), Mantle Cell Lymphoma (MCL), Blastoid Variant, Burkitt Lymphoma (BL), Aggressive Marginal Zone Lymphoma (MZL)
01/14
04/15

Download Options